Pharmacy Times October 16, 2023
Brian Cox, MBA, MSSF, FACHE, Alberto Coustasse, DrPH, MD, MBA, MPH, Monisha Gupta, PhD, Craig Kimble, PharmD, MBA, MS, BCACP

AI systems can detect minute anomalies often missed by the human eye, reducing false negatives.

Artificial intelligence (AI) has revolutionized cancer research and treatment by identifying intricate patterns in medical data and providing quantitative evaluations of clinical conditions.1 In today’s complex terrain of available medical data, AI can play a crucial role in enhancing traditional data analysis methods. Through the use of AI algorithms in image analysis and radiology, oncology professionals can detect subtle nuances in medical images, leading to early cancer detection and accurate diagnoses.2 AI also has ensured a data-driven methodology for evaluating eligibility criteria, facilitating more inclusive trial design while maintaining safeguards for patient safety.3

Additionally, AI’s impact has extended to optimizing clinical trials and refining patient...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Clinical Trials, Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider, Technology, Trends
Getting started with AI agents (part 1): Capturing processes, roles and connections
Unlocking The Genetic Code: AI Reveals New Insights Into Psychiatric Disorders
5 questions for the Abundance Institute's Neil Chilson
AI agents are unlike any technology ever
Amazon Increases Total Investment in AI Startup Anthropic to $8 Billion

Share This Article